Experimental chemotherapy of Schistosomiasis mansoni.
D000284:Administration, Oral; D000818:Animals; D000965:Antimony / Q000627:therapeutic use; D002629:Chemosterilants / Q000494:pharmacology; D002648:Child; D006224:Cricetinae; D003545:Cysteine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical / Q000379:methods; D005029:Ethylenediamines / Q000627:therapeutic use; D000882:Haplorhini; D006801:Humans; D007273:Injections, Intramuscular; D051379:Mice; D009574:Nitro Compounds / Q000627:therapeutic use; D009581:Nitrofurans / Q000627:therapeutic use; D010069:Oxadiazoles / Q000627:therapeutic use; D011437:Propylamines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D012263:Ribonucleosides / Q000627:therapeutic use; D012550:Schistosoma mansoni / Q000378:metabolism; D012552:Schistosomiasis / Q000188:drug therapy*; D012556:Schistosomicides / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use; D013892:Thioxanthenes / Q000627:therapeutic use; D014361:Trypsin Inhibitors / Q000627:therapeutic use; D014753:Vinyl Compounds / Q000627:therapeutic use
D002629:Chemosterilants; D005029:Ethylenediamines; D009574:Nitro Compounds; D009581:Nitrofurans; D010069:Oxadiazoles; D011437:Propylamines; D011743:Pyrimidines; D011758:Pyrroles; D011804:Quinolines; D012263:Ribonucleosides; D012556:Schistosomicides; D013844:Thiazoles; D013892:Thioxanthenes; D014361:Trypsin Inhibitors; D014753:Vinyl Compounds; D000965:Antimony; D003545:Cysteine